XTalks

MAY 17, 2024

The therapy is the first and only US Food and Drug Administration (FDA)-approved treatment that reduces the loss of kidney function in adults with the disease. Dr. Philipson, a medical practitioner turned pharmaceutical expert, shared insights into the space of rare disease drug development.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

pharmaphorum

FEBRUARY 1, 2022

He has worked on Visensia, the world’s first FDA-approved multivariate patient monitoring system, and the SEND system, which is now used to monitor 20,000 patients each month in the NHS. Since 2008, he has translated his work into the biomedical context for healthcare applications.

Clinical Trials 83

Clinical Trials Clinical Trials Trials Engineer 83

XTalks

MAY 29, 2024

The company focuses heavily on its product and business development and prioritizes its environmental and social responsibilities. Regeneron has grown in leaps and bounds since its first US Food and Drug Administration (FDA) approval for Arcalyst (rilonacept) in 2008. Vertex is growing at a CAGR of 28.97

Medicine 52

Medicine Marketing FDA Approval Development 52

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. The FDA approved the drug over a decade ago in September 2009. billion in 2022. billion in 2021.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

APRIL 21, 2023

Theranos’ groundbreaking developments received many patents. And in 2015 the US Food & Drug Administration (FDA) approved an assay on Theranos’ proprietary technology.” Outsiders who reviewed the technology said it worked.

Life Science 98

Life Science Trials Production Compliance 98

Pharmaceutical Technology

DECEMBER 22, 2022

The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. Sanofi wins the Product Launches award this year following the further development of its Dupixent (dupilumab) product and a string of approvals.

Insulin 130

Insulin Production Development Genetics 130

The Pharma Data

DECEMBER 8, 2020

Now poised to advance a robust therapeutics pipeline to clinical development, Nuance will use the funds for ongoing R&D of existing products and business development of potential new assets. Through its Shielded Living Therapeutics platform, the company is developing functional cures for chronic diseases.

RNA 52

RNA Antibody Life Science Protein 52

pharmaphorum

JANUARY 28, 2021

If passed, HR 8190 would allow insulin biosimilar products to receive automatic interchangeability upon FDA approval. Sean McGowan is responsible for leading strategy and business development initiatives for the Biosimilar product category at AmeriSourceBergen. About the author.

Marketing 90

Marketing Insulin HR Production 90

Drug Discovery World

APRIL 27, 2023

Dr Vaessen says that local government and business development partners work closely within the industry to attract companies like FUJIFILM Irvine Scientific to the region. As a well- known life science hub, we will benefit from the pool of talent concentrated in RTP.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Drug Discovery World

FEBRUARY 24, 2023

Abbey Vangeloff is the Director of Business Development, Life Sciences, at Yahara Software. She will be chairing a session at SLAS2023. DDW’s Megan Thomas catches up with Vangeloff to learn why AI and data science are so important for the future of the sector. I think that’s a really fascinating discipline.

Life Science 52

Life Science Drugs Bioinformatics Development 52

The Pharma Data

MAY 4, 2021

Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business (4) in the first three quarters of 2020 , is now included within the Hospital therapeutic area for all periods presented. Some amounts in this press release may not add due to rounding.

Vaccination 40

Vaccination Vaccine Production Sales 40

Drug Discovery World

SEPTEMBER 16, 2022

There is another Cell and Gene Therapy company, FinVector, in the city of Kuopio, home of Seppo Ylä-Herttuala whose work on the field for over 30 years is key to explaining the high amount of public and private activity in the area.” – CBO Aino Kalervo, and VP of Business Development? Víctor Cervera-Carrascón of Tilt Bio. .

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

The Pharma Data

NOVEMBER 5, 2020

FDA accepted for priority review Libtayo ® (cemiplimab-rwlc) for both advanced non-small cell lung cancer and basal cell carcinoma. FDA approved Inmazeb for Ebola ( Zaire ebolavirus). NASDAQ: REGN ) today announced financial results for the third quarter of 2020 and provided a business update. government.

Sales 52

Sales Production Manufacturing Antibody 52

The Pharma Data

AUGUST 3, 2021

Research & Development (R&D) expenses increased 12% primarily due to higher research and early pipeline spend and late-stage development program spend, including our recent business development activities. LUMAKRAS received accelerated approval based on overall response rate and duration of response.

Sales 52

Sales Production Antibody Development 52

The Pharma Data

AUGUST 6, 2020

FDA) approval of Opdivo (nivolumab) for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy. This approval was based on the Phase 3 CheckMate -9LA study. Oncology and Hematology. Regulatory.

Production 52

Production Branding Marketing Licensing 52

The Pharma Data

NOVEMBER 5, 2020

resolving patent litigation brought in response to Teva’s Abbreviated New Drug Application, seeking approval to market a generic version of Xtampza ER prior to the expiration of Collegium’s applicable patents. FDA approval, and customary exceptions). Reached a settlement with Teva Pharmaceutical USA, Inc.

Production 52

Production Marketing Sales Manufacturing 52